Brain Neoplasm: Clinical Trials

3 trials for Brain Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 12Completed 2

Follow Brain Neoplasm: new trials by email Literature Review of Brain Neoplasm trials Research Report on Brain Neoplasm

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
DNX-2401, pembrolizumab - Brain Cancer, Brain Neoplasm
Phase 2CompletedDNAtrix, Inc.492016-10-062021-07-15
Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.
131I-TM-601 - Glioma, Brain Neoplasm
Phase 1 / Phase 2CompletedTransMolecular182002-06-012009-03-31
Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas
Gliolan - Brain Neoplasm
Phase 1 / Phase 2Completedmedac GmbH212000-02-012016-05-23

Narrower conditions

Brain Neoplasms (3)  ·  Glioma (2)  ·  Disease (1)  ·  Glioblastoma (1)  ·  Gliosarcoma (1)  ·  Neoplasms (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Nervous System Diseases (1)  ·  Neuroectodermal Tumors (1)

Broader conditions

Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Central Nervous System Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Nervous System Neoplasms (3)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Nervous System Diseases (2)  ·  Astrocytoma (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neuroectodermal Tumors (1)  ·  Pathologic Processes (1)

Interventions

Aminolevulinic Acid (1)  ·  Antibodies, Monoclonal (1)  ·  Chlorotoxin (1)  ·  Oncolytic Virotherapy (1)  ·  pembrolizumab (1)

Sponsors

DNAtrix, Inc. (1)  ·  TransMolecular (1)  ·  medac GmbH (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Diana M Hablitz, MSNCRNP (1)  ·  Nancy Gady, BS (1)

Results publications

PMID 37188783